(Q43456888)
Statements
Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas (English)
Mats Jerkeman
Heidi Nyman
Marja-Liisa Karjalainen-Lindsberg
9 January 2009
1 reference